Philadelphia-based Rothman Orthopaedic Institute named Christopher Olivia, MD, as its new CEO.
In his role, Dr. Olivia will lead Rothman's strategic direction and growth, according to an April 21 news release. He's replacing former CEO Michael West, who held the role since 1999. Mr. West announced his retirement in February.
Dr. Olivia has worked as CEO of six health-related companies and has expertise in strategic planning and business development. In the last eight years, he devoted time to creating value-based financing and ambulatory clinical delivery models. He also worked as an ophthalmologist and received his medical degree from Philadelphia-based Hahnemann University.
Mr. West will remain as an executive adviser at Rothman through June 30 to assist the transition.
More articles on biologics:
Florida surgeon performs disc replacement on wrong area of patient's spine
2 spine surgeon leaders exit Johns Hopkins
5 high-profile device company court battles: Medtronic, Smith+Nephew & more